When: November 11th at 6:00 pm
Where: 1207 Ordean Court (Bohannon Hall 90) Duluth, MN 55812-3010
This Fall the Center is conducting a panel discussion on the legalization of medical marijuana in Minnesota. Twenty states and the District of Columbia already allow seriously ill residents to use medical marijuana with their doctors’ recommendations. The Minnesota Legislature wrapped up year one of the 2013-2014 session with the introduction of medical marijuana legislation. Rep. Carly Melin (DFL-Hibbing) introduced HF 1818 in the House, and Sen. Scott Dibble (DFL-Minneapolis) introduced the companion – SF 1641 – in the Senate.
1. Rep. Carly Melin is a member of the Minnesota Democratic-Farmer-Labor Party (DFL), she represents District 6A, which includes portions of the Iron Range in Itasca and St. Louis counties in the northeastern part of the state. Melin received a B.S. in political science from Bemidji State University and a J.D. from Hamline University School of Law. After graduating, she returned to the Iron Range to practice law, accepting a position with the Minnesota State Judiciary. Melin introduced HF 1818, a bill that would allow people with serious illnesses to access and use medical marijuana if their doctors recommend it.
2. Heather Azzi is the political director for Minnesotans for Compassionate Care. MCC is a group of organizations, medical professionals, patients and concerned citizens working to protect people with cancer, multiple sclerosis, HIV/AIDS and other serious illnesses from arrest and imprisonment for using medical marijuana with their physicians’ advice.
3. Rep. Bob Barrett is a member of the Republican Party of Minnesota; he represents District 32B, which includes portions of Chisago County just north of the Twin Cities metropolitan area. Barrett graduated from Mankato State University in Mankato, receiving his B.A. in accounting in 1989. Active in his community, he served on the Chisago Lakes School District Finance Team, and was also a school district mentor.
4. Cody Wiberg, Pharm.D., M.S., R.Ph. is the executive director of the Minnesota Board of Pharmacy. The Minnesota Board of Pharmacy exists to protect the public from adulterated, misbranded, and illicit drugs, and from unethical or unprofessional conduct on the part of pharmacists or other licensees, and to provide a reasonable assurance of professional competency in the practice of pharmacy by enforcing the Pharmacy Practice Act M.S. 151, State Controlled Substances Act M.S. 152 and various other statutes. The Board regulates pharmacists, pharmacies, pharmacy technicians, controlled substance researchers, drug wholesalers and drug manufactures. The Board approves licenses or registrations for these individuals or businesses, and also decides when to impose disciplinary action.